T2DM is characterized by dysfunction of islet β-cells, resulting in impaired insulin secretion and resistance to the actions of insulin in peripheral tissues (i.e., insulin resistance). Most diabetes mellitus individuals have at least one comorbid chronic disease and have higher risks of cardiovascular complications, end-stage renal disease, and hypertension [1,2]. The gene discussed is INS; the disease is stage 5 chronic kidney disease.